# The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus

> **NCT02882737** · NA · COMPLETED · sponsor: **Hvidovre University Hospital** · enrollment: 14 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Glucagon before exercise
- **DRUG:** Glucagon after exercise
- **DRUG:** Glucagon after resting

## Key facts

- **NCT ID:** NCT02882737
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2017-07-11
- **Final completion:** 2017-07-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2017-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02882737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02882737, "The Impact of Subcutaneous Glucagon Before, During and After Exercise a Study in Patients With Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02882737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*